Trial Profile
ARNI-study: ARNI or ARB to arrest progression of nephropathy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2017
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Valsartan
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms ARNI-study
- 31 Jul 2017 New trial record